General Inflammation Testing
Customize your policy alerts
Sign up for Blue Cross Blue Shield - Illinois Policy RPLAB049 alerts
Get alerted when Policy RPLAB049 changes without checking for updates manually.
Monitor payer policy activity
This reimbursement policy governs when C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) laboratory testing may be reimbursable based on diagnosed or suspected inflammatory conditions. It applies to providers submitting claims, subject to applicable plan documents, provider contracts, coding rules, and product-specific requirements.
Reimbursement Information item 2 was revised for clarity.
The reimbursement table, now identified as Note 1, added a CRP recommendation for Multisystem Inflammatory Syndrome in Children (MIS-C).
The reimbursement table added CRP and ESR recommendations for Pediatric Chronic Nonbacterial Osteomyelitis (CNO).
A new Note 2 was added with entry criteria for Pediatric Chronic Nonbacterial Osteomyelitis (CNO).
The label "Test Preference" in Note 1 was changed to "Test Coverage" for clarity.
The policy references were revised.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.